AUTOMATED BIOREACTOR FOR EXPANDING STEM CELLS

Information

  • Research Project
  • 6177873
  • ApplicationId
    6177873
  • Core Project Number
    R44DK052257
  • Full Project Number
    5R44DK052257-03
  • Serial Number
    52257
  • FOA Number
  • Sub Project Id
  • Project Start Date
    2/21/1997 - 27 years ago
  • Project End Date
    8/31/2001 - 23 years ago
  • Program Officer Name
    MUFSON, R. ALLAN
  • Budget Start Date
    9/1/2000 - 24 years ago
  • Budget End Date
    8/31/2001 - 23 years ago
  • Fiscal Year
    2000
  • Support Year
    3
  • Suffix
  • Award Notice Date
    8/14/2000 - 24 years ago
Organizations

AUTOMATED BIOREACTOR FOR EXPANDING STEM CELLS

Description: (Adapted form the applicant's abstract): This is a revised SBIR Phase II application. The proposal seeks to develop an automated cell culture and analysis system for single cells and apply this system to study of the growth of human hematopoietic stem cells. The approach is based on the hypothesis that an automated single cell bioreactor can be designed and constructed and that this system will provide a tool to advance the basic scientists' ability to dissect the basic biology of cell division and differentiation and to discover how to expand human hematopoietic stem cells in vitro. The system to be developed is a robotic system that intends to automate the processes of: 1) of cell culture and provide information at the level of individual cells; 2) screening of the effects of biological or chemical moieties on tissue-specific cells; and 3) manipulating the fluid microenvironment of cells based upon real-time identification of changes in cell state (e.g., cell division, cell phenotype, apoptosis, etc.). In this Phase II project, the performance and image processing capability of the existing system will be improved and validated; once these tasks are completed, the system's capabilities will be expanded in terms of throughput and the quality and quantity of information obtained. Applications and testing protocols developed in the Phase II program will be directed at the system's use to understand the cell biology of hematopoietic stem cells although the system ultimately would have a number of biological and drug discovery applications. PROPOSED COMMERCIAL APPLICATION: NOT AVAILABLE

IC Name
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES
  • Activity
    R44
  • Administering IC
    DK
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    375573
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    847
  • Ed Inst. Type
  • Funding ICs
    NIDDK:375573\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    AUTOMATED CELL, INC.
  • Organization Department
  • Organization DUNS
    159699008
  • Organization City
    PITTSBURGH
  • Organization State
    PA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    152381329
  • Organization District
    UNITED STATES